Laserfiche WebLink
<br />Attachment C <br /> <br />Section 9 Medical SUDDlies and Limited TVDes of Pharmaceuticals <br /> <br />AEL Ref No Title / Description <br />SHSP/ LETPP MMRS EMPG <br />VASI <br /> <br />Fall 2004 <br />SEL Ref Number <br /> <br />9.2.40 <br />~DDD <br /> <br />09MS-01-KDEB <br /> <br />9.2.41 <br />~DDD <br /> <br />9.2.42 <br />~DDD <br /> <br />Kit, Debridement, and Supplies <br />SingleMuse, disposable kit to clean soft tissue injuries and surfaces. <br /> <br />Kit, Obstetrical <br />Self.contained kit with supplies required to support obstetrical procedures. <br /> <br />Kit, Thoracostomy and Supplies <br />Self contained kit to perform and support chest decompression. <br /> <br />(9.3) Pharmaceuticals <br /> <br />9.3.0 <br />~DDD <br /> <br />9.3.1 <br />~DDD <br /> <br />9.3.2 <br />~DDD <br /> <br />9.3.3 <br />~DDD <br /> <br />9.3.4 <br />~DDD <br /> <br />9.3.5 <br />~DDD <br /> <br />9.3.6 <br />~DDD <br /> <br />9.3.7 <br />~DDD <br /> <br />9.3.8 <br />~DDD <br /> <br />Pharmaceuticals <br /> <br />Various pharmaceuticals required for response to a CBRNE terrorism <br />incident at the advanced life support level. Note that grantees are <br />responsible for replenishing items after shelf-life expiration dates. <br /> <br />Adamantines <br /> <br />Anti-viral; FDA approved to treat and prevent INFLUENZA A viruses. <br />Includes amantadine and rimantadine. Described in Federal Pandemic <br />Influenza Preparedness and Response Plan: <br />http://www.hhs.gov/nvpo/pandemicplan <br />Sample fact sheets available at: <br />http://www.niaid.nih.gov/factsheetslfludrugs.htm <br />http://hopkins-heic.orgfinfectious_diseases/inftuenzalfacts.htm <br /> <br />Adenosine <br />Anti-dysrhythmic <br /> <br />Albuterol <br />Bronchodilator <br /> <br />Amiodarone <br />Anti-dysrhythmic <br /> <br />Amyl Nitrite <br />Vasodilator <br /> <br />Antacids <br />Antacid <br /> <br />Acetylsalicylic Acid <br />Anticoagulant; analgesic, anti-inftammatory; fever reduction. <br /> <br />Atropine Sulfate <br />Antidote for organophosphate and nerve agent exposure. <br /> <br />09MS-01-KTOB <br /> <br />09MS-Ol-THOR <br /> <br />09PH-OO-ADAM <br /> <br />09PH-OO-ADEN <br /> <br />09PH-OO-ALBU <br /> <br />09PH-OO-AMIO <br /> <br />09PH-OO-AMNI <br /> <br />09PH-OO-ANTA <br /> <br />09PH-OO-ASA <br /> <br />09PH-OO-ATSF <br /> <br />Interactive versions of this appendix and the Fall 2004 SEL are available on-line at www.rkb.miptorg. <br />Wednesday, April 27, 2005 Futl AEL: Page 49 0[78 <br />